Please use this identifier to cite or link to this item: https://doi.org/10.1158/1078-0432.CCR-10-3152
DC FieldValue
dc.titleGenomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer
dc.contributor.authorOh, H.-K.
dc.contributor.authorTan, A.L.-K.
dc.contributor.authorDas, K.
dc.contributor.authorOoi, C.-H.
dc.contributor.authorDeng, N.-T.
dc.contributor.authorTan, I.B.
dc.contributor.authorBeillard, E.
dc.contributor.authorLee, J.
dc.contributor.authorRamnarayanan, K.
dc.contributor.authorRha, S.-Y.
dc.contributor.authorPalanisamy, N.
dc.contributor.authorVoorhoeve, P.M.
dc.contributor.authorTan, P.
dc.date.accessioned2014-11-26T09:04:17Z
dc.date.available2014-11-26T09:04:17Z
dc.date.issued2011-05-01
dc.identifier.citationOh, H.-K., Tan, A.L.-K., Das, K., Ooi, C.-H., Deng, N.-T., Tan, I.B., Beillard, E., Lee, J., Ramnarayanan, K., Rha, S.-Y., Palanisamy, N., Voorhoeve, P.M., Tan, P. (2011-05-01). Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clinical Cancer Research 17 (9) : 2657-2667. ScholarBank@NUS Repository. https://doi.org/10.1158/1078-0432.CCR-10-3152
dc.identifier.issn10780432
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/110550
dc.description.abstractPurpose: MicroRNAs (miRNA) play pivotal oncogenic and tumor-suppressor roles in several human cancers. We sought to discover novel tumor-suppressor miRNAs in gastric cancer (GC). Experimental Design: Using Agilent miRNA microarrays, we compared miRNA expression profiles of 40 primary gastric tumors and 40 gastric normal tissues, identifying miRNAs significantly downregulated in gastric tumors. Results: Among the top 80 miRNAs differentially expressed between gastric tumors and normals (false discovery rate < 0.01), we identified hsa-miR-486 (miR-486) as a significantly downregulated miRNA in primary GCs and GC cell lines. Restoration of miR-486 expression in GC cell lines (YCC3, SCH and AGS) caused suppression of several pro-oncogenic traits, whereas conversely inhibiting miR-486 expression in YCC6 GC cells enhanced cellular proliferation. Array-CGH analysis of 106 primary GCs revealed genomic loss of the miR-486 locus in approximately 25% to 30% of GCs, including two tumors with focal genomic losses specifically deleting miR-486, consistent with miR-486 playing a tumor-suppressive role. Bioinformatic analysis identified the secreted antiapoptotic glycoprotein OLFM4 as a potential miR-486 target. Restoring miR-486 expression in GC cells decreased endogenous OLFM4 transcript and protein levels, and also inhibited expression of luciferase reporters containing an OLFM4 3′ untranslated region with predicted miR-486 binding sites. Supporting the biological relevance of OLFM4 as a miR-486 target, proliferation in GC cells was also significantly reduced by OLFM4 silencing. Conclusions: miR-486 may function as a novel tumor-suppressor miRNA in GC. Its antioncogenic activity may involve the direct targeting and inhibition of OLFM4. ©2011 AACR.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1158/1078-0432.CCR-10-3152
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentDUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
dc.description.doi10.1158/1078-0432.CCR-10-3152
dc.description.sourcetitleClinical Cancer Research
dc.description.volume17
dc.description.issue9
dc.description.page2657-2667
dc.description.codenCCREF
dc.identifier.isiut000290093600008
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.